1. Home
  2. SHIP vs AGEN Comparison

SHIP vs AGEN Comparison

Compare SHIP & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seanergy Maritime Holdings Corp.

SHIP

Seanergy Maritime Holdings Corp.

HOLD

Current Price

$17.63

Market Cap

335.9M

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$7.54

Market Cap

274.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHIP
AGEN
Founded
2008
1994
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.9M
274.8M
IPO Year
2008
1999

Fundamental Metrics

Financial Performance
Metric
SHIP
AGEN
Price
$17.63
$7.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$23.25
★ $26.33
AVG Volume (30 Days)
405.8K
★ 1.1M
Earning Date
11-12-2026
11-09-2026
Dividend Yield
★ 2.49%
N/A
EPS Growth
N/A
★ 100.00
EPS
N/A
★ 0.96
Revenue
N/A
★ $42,877,086.00
Revenue This Year
$27.31
$9.64
Revenue Next Year
N/A
N/A
P/E Ratio
$13.34
★ $7.89
Revenue Growth
N/A
★ 89.95
52 Week Low
$7.66
$2.71
52 Week High
$19.22
$10.19

Technical Indicators

Market Signals
Indicator
SHIP
AGEN
Relative Strength Index (RSI) 51.78 44.90
Support Level $15.92 $3.04
Resistance Level $19.20 $8.64
Average True Range (ATR) 0.61 0.69
MACD -0.04 -0.17
Stochastic Oscillator 49.02 8.64

Price Performance

Historical Comparison
SHIP
AGEN

About SHIP Seanergy Maritime Holdings Corp.

Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through a modern fleet of Capesize vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: